Rifa Metrogyl Tablet
By Rifa Metrogyl
Rx
10 Tablet in a Strip

Composition
Rifaximin(200mg) + Metronidazole(400mg)

Manufacturer - J B Chemicals and Pharmaceuticals Ltd
Cnergy IT Park, 3rd floor Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400025

Expires on or after
November, 2025

liver
When using Rifa Metrogyl Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require dose adjustments when taking this medication. It is recommended to consult with your doctor regarding the use of Rifa Metrogyl Tablet to ensure its safety and effectiveness for individuals with liver conditions.

kidney
Rifa Metrogyl Tablet appears safe for patients with kidney disease. Data shows dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
Caution is advised when consuming alcohol with Rifa Metrogyl Tablet, as it may result in symptoms like flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure (known as Disulfiram reaction).

driving
Caution - Driving Rifa Metrogyl Tablet may cause sleepiness, dizziness, confusion, hallucinations, fits, or temporary vision problems, which can impair driving ability.

pregnancy
Rifa Metrogyl Tablet may be unsafe during pregnancy, as animal studies suggest harm to the developing baby. Consult your doctor to evaluate benefits and risks before use.

breastfeeding
Rifa Metrogyl Tablet is likely safe to use while breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹158.4
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025